Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality.

Pyka Ł, Hudzik B, Bartuś S, Buszman P, Gierlotka M, Wojakowski W, Hiczkiewicz J, Kleinrok A, Skrzypek M, Kuliczkowski W, Gąsior M

Open source

DOI
10.1177/10742484231212106
Published
2023 Jan-Dec
Container
Journal of cardiovascular pharmacology and therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10742484231212106,
  title = {Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality.},
  author = {Pyka Ł and Hudzik B and Bartuś S and Buszman P and Gierlotka M and Wojakowski W and Hiczkiewicz J and Kleinrok A and Skrzypek M and Kuliczkowski W and Gąsior M},
  year = {2023},
  journal = {Journal of cardiovascular pharmacology and therapeutics},
  doi = {10.1177/10742484231212106},
  url = {https://doi.org/10.1177/10742484231212106}
}

RIS

TY  - JOUR
TI  - Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality.
AU  - Pyka Ł
AU  - Hudzik B
AU  - Bartuś S
AU  - Buszman P
AU  - Gierlotka M
AU  - Wojakowski W
AU  - Hiczkiewicz J
AU  - Kleinrok A
AU  - Skrzypek M
AU  - Kuliczkowski W
AU  - Gąsior M
PY  - 2023
JO  - Journal of cardiovascular pharmacology and therapeutics
DO  - 10.1177/10742484231212106
UR  - https://doi.org/10.1177/10742484231212106
ER  - 

APA

Ł, P., B, H., S, B., P, B., M, G., W, W., J, H., A, K., M, S., W, K., & M, G. (2023). Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality.. Journal of cardiovascular pharmacology and therapeutics. https://doi.org/10.1177/10742484231212106

Source records